Key takeaway
The European Ombudsman has urged the European Commission to address significant delays in its authorisation process for dangerous chemical substances under the REACH Regulation. Despite a statutory three-month deadline, the Commission is taking an average of 14.5 months, with some cases exceeding 54 months. These delays allow hazardous chemicals, which pose risks such as carcinogenicity and toxicity, to remain on the market without adequate oversight. The Ombudsman found this to be maladministration and recommended that the Commission streamline its internal procedures, reject incomplete applications, and improve transparency in the decision-making process. The Commission has been asked to provide a detailed response by January 2025.
The Ombudsman has recommended that the European Commission overhaul its internal processes to meet the statutory three-month deadline for decision-making on dangerous chemical substances. This includes promptly rejecting incomplete applications to prevent companies from using hazardous substances while awaiting decisions. Additionally, the Ombudsman urged for greater transparency in the process, including more detailed public reporting on the progress of each authorisation.
The Ombudsman found that the European Commission lacks transparency in its decision-making process. The public has limited access to information on the progress of authorisations and the reasons for delays. To address this, the Ombudsman recommended that the Commission provide more detailed and timely reports from the REACH Committee meetings, allowing the public to track decisions and hold relevant parties accountable.
Source basis: https://www.ombudsman.europa.eu/en/news-document/en/194266
The European Ombudsman has issued a recommendation urging the European Commission to address delays in its authorisation process for dangerous chemical substances under the REACH Regulation. Despite a statutory deadline of three months, the Commission has taken an average of 14.5 months—and in some cases, up to 54 months—to reach decisions, leading to extended use of hazardous chemicals in the EU.
The inquiry, opened in June 2023, found that the European Commission’s failure to meet statutory deadlines for processing applications to authorise the use of dangerous chemical substances constitutes maladministration. The substances in question pose significant risks, including carcinogenic, mutagenic, and toxic properties. The REACH Regulation mandates that companies applying for authorisation must submit detailed information to justify the continued use of these chemicals while their applications are pending. However, systemic delays mean that many of these hazardous substances remain on the market for extended periods, without adequate oversight or control.
The report highlights several reasons behind these delays. The Commission cited internal complexities, such as the involvement of two directorates-general—Environment (DG ENV) and Internal Market, Industry, Entrepreneurship and SMEs (DG GROW)—in processing applications. Additional complications arise from the need to reconcile technical advice from expert committees and the need for broader political deliberations. In some cases, incomplete applications further slow down the process.
Moreover, the inquiry revealed that only 20% of authorisation procedures were completed within 12 months, while the remaining 80% took far longer. The Ombudsman expressed concern that such delays contradict the core aim of the REACH Regulation—to protect public health and the environment.
The Ombudsman’s recommendation emphasises that the Commission must reorganise its procedures to ensure timely decisions and suggests rejecting incomplete applications to prevent companies from continuing to use dangerous substances. Furthermore, the Ombudsman has called for increased transparency, particularly around the workings of the REACH Committee, which approves the final decisions. The lack of publicly available information hampers public accountability and understanding of the reasons for delays.
Two recent EU court cases underline the gravity of the issue. In both cases, the Commission’s authorisations were annulled due to inadequate consideration of risks or alternatives. The courts ruled that applicants bear the burden of proof and that incomplete applications should not be allowed to prolong the use of dangerous substances.
The Ombudsman’s recommendation could prompt significant changes in how the Commission handles chemical risk management. Ensuring compliance with the three-month statutory deadline is critical to fulfilling the regulation’s purpose: the timely phasing out of harmful chemicals.
The European Ombudsman’s intervention underscores the urgent need for the European Commission to streamline its authorisation process for dangerous chemical substances. Delays not only pose risks to public health and the environment but also undermine the credibility of the EU’s regulatory framework. The Commission has been urged to revise its procedures to enhance both efficiency and transparency, ensuring that hazardous substances are regulated with the urgency they demand.
The Ombudsman’s full recommendation is expected to influence future regulatory practices, with a detailed response from the Commission due by January 2025.
The February 2026 REACH Committee meeting focused on reviewing draft restrictions and authorisations for lead, chromium VI and CMR substances. While no major measures were finalised, the discussions indicate continued regulatory scrutiny and signal important developments ahead of expected votes in April.
The proposed CLP Annex VI update introduces harmonised classifications for over 100 hazardous substances, including SVHCs, PFAS and endocrine disruptors. The changes will impact labelling, safety data and product formulation across multiple sectors, requiring early compliance planning and supply chain engagement.
Discover the proposal to classify formaldehyde as an SVHC, its industrial uses, associated risks, and how industries can prepare for regulatory changes.
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
